APO Research
Talk to an analyst

APO RESEARCH · REPORT

Modafinil Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Modafinil Tablets Market Outlook and Growth Opportunities 2026

27 December 2025191 pages

Choose your research edition.

Industry ResearchModafinil Tablets Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Modafinil Tablets Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Modafinil Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Modafinil Tablets Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Modafinil Tablets Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Modafinil Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Modafinil Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Modafinil Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Modafinil Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Modafinil Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Modafinil Tablets market include Zydus, Watson Labs, Sun Pharmaceutical, Orbion Pharmaceuticals, Cephalon, Aurobindo Pharma, Apotex and Alembic Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Modafinil Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Modafinil Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Modafinil Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Modafinil Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Modafinil Tablets Segment by Company

Zydus

Watson Labs

Sun Pharmaceutical

Orbion Pharmaceuticals

Cephalon

Aurobindo Pharma

Apotex

Alembic Pharma

Modafinil Tablets Segment by Type

100mg per Tablet

200mg per Tablet

Modafinil Tablets Segment by Application

Obstructive Sleep Apnea

Shift Work Sleep Disorder

Narcolepsy

Other

Modafinil Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Modafinil Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Modafinil Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Modafinil Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Modafinil Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Modafinil Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Modafinil Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Modafinil Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Modafinil Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Modafinil Tablets industry.

Chapter 3: Detailed analysis of Modafinil Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Modafinil Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Modafinil Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Modafinil Tablets Industry Trends Table 2. Modafinil Tablets Industry Drivers Table 3. Modafinil Tablets Industry Opportunities and Challenges Table 4. Modafinil Tablets Industry Restraints Table 5. Global Modafinil Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Modafinil Tablets Revenue Share by Company (2021-2026) Table 7. Global Modafinil Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Modafinil Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Modafinil Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Modafinil Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Modafinil Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Modafinil Tablets Company, Product Type & Application Table 13. Global Modafinil Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Modafinil Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 100mg per Tablet Table 18. Significant Companies of 200mg per Tablet Table 19. Global Modafinil Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Modafinil Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Modafinil Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Modafinil Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Modafinil Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Modafinil Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Modafinil Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Modafinil Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Modafinil Tablets Sales Value Share by Type (2021-2026) Table 28. Global Modafinil Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Obstructive Sleep Apnea Table 30. Significant Companies of Shift Work Sleep Disorder Table 31. Significant Companies of Narcolepsy Table 32. Significant Companies of Other Table 33. Global Modafinil Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Modafinil Tablets Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Modafinil Tablets Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Modafinil Tablets Sales Volume Share by Application (2021-2026) Table 37. Global Modafinil Tablets Sales Volume Share by Application (2027-2032) Table 38. Global Modafinil Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Modafinil Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Modafinil Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Modafinil Tablets Sales Value Share by Application (2021-2026) Table 42. Global Modafinil Tablets Sales Value Share by Application (2027-2032) Table 43. Global Modafinil Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Modafinil Tablets Sales by Region (2021-2026) & (K Units) Table 45. Global Modafinil Tablets Sales Market Share by Region (2021-2026) Table 46. Global Modafinil Tablets Sales by Region (2027-2032) & (K Units) Table 47. Global Modafinil Tablets Sales Market Share by Region (2027-2032) Table 48. Global Modafinil Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Modafinil Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Modafinil Tablets Sales Value Share by Region (2021-2026) Table 51. Global Modafinil Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Modafinil Tablets Sales Value Share by Region (2027-2032) Table 53. Global Modafinil Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Modafinil Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Modafinil Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Modafinil Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Modafinil Tablets Sales by Country (2021-2026) & (K Units) Table 58. Global Modafinil Tablets Sales Market Share by Country (2021-2026) Table 59. Global Modafinil Tablets Sales by Country (2027-2032) & (K Units) Table 60. Global Modafinil Tablets Sales Market Share by Country (2027-2032) Table 61. Global Modafinil Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Modafinil Tablets Sales Value Market Share by Country (2021-2026) Table 63. Global Modafinil Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Modafinil Tablets Sales Value Market Share by Country (2027-2032) Table 65. Zydus Company Information Table 66. Zydus Business Overview Table 67. Zydus Modafinil Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Zydus Modafinil Tablets Product Portfolio Table 69. Zydus Recent Development Table 70. Watson Labs Company Information Table 71. Watson Labs Business Overview Table 72. Watson Labs Modafinil Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Watson Labs Modafinil Tablets Product Portfolio Table 74. Watson Labs Recent Development Table 75. Sun Pharmaceutical Company Information Table 76. Sun Pharmaceutical Business Overview Table 77. Sun Pharmaceutical Modafinil Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Sun Pharmaceutical Modafinil Tablets Product Portfolio Table 79. Sun Pharmaceutical Recent Development Table 80. Orbion Pharmaceuticals Company Information Table 81. Orbion Pharmaceuticals Business Overview Table 82. Orbion Pharmaceuticals Modafinil Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Orbion Pharmaceuticals Modafinil Tablets Product Portfolio Table 84. Orbion Pharmaceuticals Recent Development Table 85. Cephalon Company Information Table 86. Cephalon Business Overview Table 87. Cephalon Modafinil Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Cephalon Modafinil Tablets Product Portfolio Table 89. Cephalon Recent Development Table 90. Aurobindo Pharma Company Information Table 91. Aurobindo Pharma Business Overview Table 92. Aurobindo Pharma Modafinil Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Aurobindo Pharma Modafinil Tablets Product Portfolio Table 94. Aurobindo Pharma Recent Development Table 95. Apotex Company Information Table 96. Apotex Business Overview Table 97. Apotex Modafinil Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Apotex Modafinil Tablets Product Portfolio Table 99. Apotex Recent Development Table 100. Alembic Pharma Company Information Table 101. Alembic Pharma Business Overview Table 102. Alembic Pharma Modafinil Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Alembic Pharma Modafinil Tablets Product Portfolio Table 104. Alembic Pharma Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Modafinil Tablets Distributors List Table 108. Modafinil Tablets Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Modafinil Tablets Product Image Figure 2. Global Modafinil Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Modafinil Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Modafinil Tablets Sales (2021-2032) & (K Units) Figure 5. Global Modafinil Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Modafinil Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 100mg per Tablet Image Figure 10. 200mg per Tablet Image Figure 11. Global Modafinil Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Modafinil Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Modafinil Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Modafinil Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Modafinil Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Modafinil Tablets Sales Value Share by Type (2021-2032) Figure 17. Obstructive Sleep Apnea Image Figure 18. Shift Work Sleep Disorder Image Figure 19. Narcolepsy Image Figure 20. Other Image Figure 21. Global Modafinil Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Modafinil Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Modafinil Tablets Sales Volume Share by Application (2021-2032) Figure 24. Global Modafinil Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Modafinil Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Modafinil Tablets Sales Value Share by Application (2021-2032) Figure 27. Global Modafinil Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Modafinil Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Modafinil Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Modafinil Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Modafinil Tablets Sales Value (2021-2032) & (US$ Million) Figure 32. North America Modafinil Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Modafinil Tablets Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Modafinil Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Modafinil Tablets Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Modafinil Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Modafinil Tablets Sales Value (2021-2032) & (US$ Million) Figure 38. South America Modafinil Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Modafinil Tablets Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Modafinil Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Modafinil Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Modafinil Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Modafinil Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Modafinil Tablets Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Modafinil Tablets Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg per Tablet
  • 200mg per Tablet
Applications
  • Obstructive Sleep Apnea
  • Shift Work Sleep Disorder
  • Narcolepsy
  • Other
Companies covered
  • Zydus
  • Watson Labs
  • Sun Pharmaceutical
  • Orbion Pharmaceuticals
  • Cephalon
  • Aurobindo Pharma
  • Apotex
  • Alembic Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Modafinil Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Modafinil Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Modafinil Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Modafinil Tablets Market Dynamics
  1. 2.1 Modafinil Tablets Industry Trends
  2. 2.2 Modafinil Tablets Industry Drivers
  3. 2.3 Modafinil Tablets Industry Opportunities and Challenges
  4. 2.4 Modafinil Tablets Industry Restraints
3 Modafinil Tablets Market by Company
  1. 3.1 Global Modafinil Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Modafinil Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Modafinil Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Modafinil Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Modafinil Tablets Company Ranking (2024-2026)
  6. 3.6 Global Modafinil Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Modafinil Tablets Company Product Type and Application
  8. 3.8 Global Modafinil Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Modafinil Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Modafinil Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Modafinil Tablets Market by Type
  1. 4.1 Modafinil Tablets Type Introduction
  2. 4.1.1 100mg per Tablet
  3. 4.1.2 200mg per Tablet
  4. 4.2 Global Modafinil Tablets Sales Volume by Type
  5. 4.2.1 Global Modafinil Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Modafinil Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Modafinil Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Modafinil Tablets Sales Value by Type
  9. 4.3.1 Global Modafinil Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Modafinil Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Modafinil Tablets Sales Value Share by Type (2021-2032)
5 Modafinil Tablets Market by Application
  1. 5.1 Modafinil Tablets Application Introduction
  2. 5.1.1 Obstructive Sleep Apnea
  3. 5.1.2 Shift Work Sleep Disorder
  4. 5.1.3 Narcolepsy
  5. 5.1.4 Other
  6. 5.2 Global Modafinil Tablets Sales Volume by Application
  7. 5.2.1 Global Modafinil Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Modafinil Tablets Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Modafinil Tablets Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Modafinil Tablets Sales Value by Application
  11. 5.3.1 Global Modafinil Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Modafinil Tablets Sales Value by Application (2021-2032)
  13. 5.3.3 Global Modafinil Tablets Sales Value Share by Application (2021-2032)
6 Modafinil Tablets Regional Sales and Value Analysis
  1. 6.1 Global Modafinil Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Modafinil Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Modafinil Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Modafinil Tablets Sales by Region (2027-2032)
  5. 6.3 Global Modafinil Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Modafinil Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Modafinil Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Modafinil Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Modafinil Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Modafinil Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Modafinil Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Modafinil Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Modafinil Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Modafinil Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Modafinil Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Modafinil Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Modafinil Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Modafinil Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Modafinil Tablets Sales Value Share by Country, 2025 VS 2032
7 Modafinil Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Modafinil Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Modafinil Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Modafinil Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Modafinil Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Modafinil Tablets Sales by Country (2027-2032)
  6. 7.4 Global Modafinil Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Modafinil Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Modafinil Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Modafinil Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Modafinil Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Modafinil Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Modafinil Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Modafinil Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Modafinil Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Modafinil Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Modafinil Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Modafinil Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Modafinil Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Modafinil Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Modafinil Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Modafinil Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Modafinil Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Modafinil Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Modafinil Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Modafinil Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Modafinil Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Modafinil Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Modafinil Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Modafinil Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Modafinil Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Modafinil Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Modafinil Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Modafinil Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Modafinil Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Modafinil Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Modafinil Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Modafinil Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Modafinil Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zydus
  2. 8.1.1 Zydus Company Information
  3. 8.1.2 Zydus Business Overview
  4. 8.1.3 Zydus Modafinil Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zydus Modafinil Tablets Product Portfolio
  6. 8.1.5 Zydus Recent Developments
  7. 8.2 Watson Labs
  8. 8.2.1 Watson Labs Company Information
  9. 8.2.2 Watson Labs Business Overview
  10. 8.2.3 Watson Labs Modafinil Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Watson Labs Modafinil Tablets Product Portfolio
  12. 8.2.5 Watson Labs Recent Developments
  13. 8.3 Sun Pharmaceutical
  14. 8.3.1 Sun Pharmaceutical Company Information
  15. 8.3.2 Sun Pharmaceutical Business Overview
  16. 8.3.3 Sun Pharmaceutical Modafinil Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sun Pharmaceutical Modafinil Tablets Product Portfolio
  18. 8.3.5 Sun Pharmaceutical Recent Developments
  19. 8.4 Orbion Pharmaceuticals
  20. 8.4.1 Orbion Pharmaceuticals Company Information
  21. 8.4.2 Orbion Pharmaceuticals Business Overview
  22. 8.4.3 Orbion Pharmaceuticals Modafinil Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Orbion Pharmaceuticals Modafinil Tablets Product Portfolio
  24. 8.4.5 Orbion Pharmaceuticals Recent Developments
  25. 8.5 Cephalon
  26. 8.5.1 Cephalon Company Information
  27. 8.5.2 Cephalon Business Overview
  28. 8.5.3 Cephalon Modafinil Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Cephalon Modafinil Tablets Product Portfolio
  30. 8.5.5 Cephalon Recent Developments
  31. 8.6 Aurobindo Pharma
  32. 8.6.1 Aurobindo Pharma Company Information
  33. 8.6.2 Aurobindo Pharma Business Overview
  34. 8.6.3 Aurobindo Pharma Modafinil Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Aurobindo Pharma Modafinil Tablets Product Portfolio
  36. 8.6.5 Aurobindo Pharma Recent Developments
  37. 8.7 Apotex
  38. 8.7.1 Apotex Company Information
  39. 8.7.2 Apotex Business Overview
  40. 8.7.3 Apotex Modafinil Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Apotex Modafinil Tablets Product Portfolio
  42. 8.7.5 Apotex Recent Developments
  43. 8.8 Alembic Pharma
  44. 8.8.1 Alembic Pharma Company Information
  45. 8.8.2 Alembic Pharma Business Overview
  46. 8.8.3 Alembic Pharma Modafinil Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Alembic Pharma Modafinil Tablets Product Portfolio
  48. 8.8.5 Alembic Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Modafinil Tablets Value Chain Analysis
  2. 9.1.1 Modafinil Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Modafinil Tablets Sales Mode & Process
  6. 9.2 Modafinil Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Modafinil Tablets Distributors
  9. 9.2.3 Modafinil Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst